European Union:
COVID-19 Key EU Developments, Policy & Regulatory Update No. 21
01 September 2020
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
This regular update (no. 21 | 8 September 2020) covers key
regulatory EU developments related to the evolving COVID-19
situation (Antitrust & State Aid; Trade/Export Controls;
Medicines, Medical Devices and Personal Protective Equipment; and
Cybersecurity, Privacy & Data Protection).
Attachments
COVID19 KEY EU DEVELOPMENTS No 21 8
Sept 20
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Coronavirus (COVID-19) from European Union
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Employee Handbook Updates REQUIRED
Epps & Coulson
Update your employee handbooks! The California Legislature passed a whole slew of workplace reform bills that took effect January 1st.